Effort to repeal 2.3% device tax will continue, AdvaMed says

01/3/2013 | MassDevice.com (Boston)

The 2.3% medical device tax has taken effect after Congress reached a deal to prevent the "fiscal cliff" on Tuesday. The industry, however, has vowed to continue the push to repeal the levy, which AdvaMed President and CEO Stephen Ubl said has bipartisan support "premised on the recognition that the tax is costing jobs and threatening patient care."

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN